World / Science & Health Aug 11, 2015
Novavax says vaccine proving effective against RSV in early studies with seniors
Early research in older adults found an experimental vaccine prevented nearly two-thirds of serious cases of a common, seasonal respiratory virus that annually kills thousands of vulnerable people — babies and senior citizens. If further testing by vaccine developer Novavax Inc. goes well, in a ...